Lushang Freda Pharmaceutical Co. Ltd. (600223)
Market Closed
11 Aug, 06:57
SSE SSE Primary ¥
5. 66
-0.04
-0.7018%
¥
7.34B Market Cap
- P/E Ratio
0.2% Div Yield
8M Volume
- Eps
¥ 5.7
Previous Close Want to track 600223 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.05 |
| | | - | 0.01 |
| | | - | 0.02 |
| | | - | 0.03 |
| | | - | 0.04 |
| | | - | 0.02 |
| | | - | 0.08 |
| | | - | 0.08 |
| | | - | 0.02 |
| | | - | 0.03 |
| | | - | 0.16 |
| | | - | 0.06 |
| | | - | 0.02 |
| | | - | 0.02 |
| | | - | 0.2 |
600223 Earnings Reports FAQ
What is the earnings per share (EPS) for 600223?
EPS data for 600223 is currently not available, as Lushang Freda Pharmaceutical Co. Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 13 years, the earnings growth rate has been approximately -38.63%, reflecting the 600223's performance and SSE market conditions.
When is the next earnings release date?
Lushang Freda Pharmaceutical Co. Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Lushang Freda Pharmaceutical Co. Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 600223 at this time, as Lushang Freda Pharmaceutical Co. Ltd has no recent EPS data to calculate it.
